Triple
T17665997
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | David Semple |
E440382
|
entity |
| Predicate | notableFor |
P22
|
FINISHED |
| Object | Semple-type rabies vaccine |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Semple-type rabies vaccine | Statement: [David Semple, notableFor, Semple-type rabies vaccine]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Semple-type rabies vaccine Context triple: [David Semple, notableFor, Semple-type rabies vaccine]
-
A.
Spikevax
Spikevax is Moderna’s mRNA-based COVID-19 vaccine used worldwide to prevent infection and severe disease caused by the SARS-CoV-2 virus.
-
B.
rabies virus
Rabies virus is a deadly neurotropic virus that causes acute encephalitis in mammals, including humans, and is almost invariably fatal once clinical symptoms appear.
-
C.
rVSV-ZEBOV
rVSV-ZEBOV is an experimental recombinant vesicular stomatitis virus-based vaccine developed to protect humans against infection by the Zaire strain of the Ebola virus.
-
D.
E*Vax
E*Vax is the stage name of Evan Mast, an American electronic musician and producer best known as one half of the duo Ratatat.
-
E.
Sendai virus vectors
Sendai virus vectors are non-integrating RNA viral delivery systems widely used to reprogram somatic cells into induced pluripotent stem cells by transiently expressing reprogramming factors.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Semple-type rabies vaccine Target entity description: The Semple-type rabies vaccine is an early nerve-tissue–based rabies vaccine developed by British bacteriologist David Semple, historically used for post-exposure prophylaxis before modern cell-culture vaccines became standard.
-
A.
Spikevax
Spikevax is Moderna’s mRNA-based COVID-19 vaccine used worldwide to prevent infection and severe disease caused by the SARS-CoV-2 virus.
-
B.
rabies virus
Rabies virus is a deadly neurotropic virus that causes acute encephalitis in mammals, including humans, and is almost invariably fatal once clinical symptoms appear.
-
C.
rVSV-ZEBOV
rVSV-ZEBOV is an experimental recombinant vesicular stomatitis virus-based vaccine developed to protect humans against infection by the Zaire strain of the Ebola virus.
-
D.
E*Vax
E*Vax is the stage name of Evan Mast, an American electronic musician and producer best known as one half of the duo Ratatat.
-
E.
Sendai virus vectors
Sendai virus vectors are non-integrating RNA viral delivery systems widely used to reprogram somatic cells into induced pluripotent stem cells by transiently expressing reprogramming factors.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8b9e87e18819087104a44dc4dc5b1 |
completed | April 10, 2026, 8:50 a.m. |
| NER | Named-entity recognition | batch_69e46ea9d91c81908414ef38c7fb36a4 |
completed | April 19, 2026, 5:56 a.m. |
Created at: April 10, 2026, 9:56 a.m.